Guardant Health, Inc. SEC filings GH

Guardant Health, Inc. has 1,003 filings in SEC EDGAR's recent list, going back to Jun 5, 2020. Its latest annual report, Form ARS, was filed on Apr 28, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

Guardant Health, Inc. SEC filings
Form Description Filed Period
S-3ASR Automatic shelf registration Jul 30, 2026 —
S-8 Employee stock plan registration Feb 20, 2026 —
424B5 Prospectus supplement Nov 6, 2025 —
FWP Free writing prospectus Nov 5, 2025 —
FWP Free writing prospectus Nov 4, 2025 —
424B5 Prospectus supplement Nov 4, 2025 —
S-8 Employee stock plan registration Feb 24, 2025 —
424B5 Prospectus supplement Aug 23, 2024 —
S-8 Employee stock plan registration Feb 23, 2024 —
424B5 Prospectus supplement Dec 21, 2023 —
S-8 Employee stock plan registration Aug 10, 2023 —
424B5 Prospectus supplement May 24, 2023 —
424B5 Prospectus supplement May 22, 2023 —
S-3ASR Automatic shelf registration May 22, 2023 —
S-8 Employee stock plan registration Mar 2, 2023 —
S-8 Employee stock plan registration Feb 28, 2022 —
S-8 Employee stock plan registration Mar 1, 2021 —
424B7 Filing Oct 8, 2020 —
424B7 Filing Oct 6, 2020 —

Showing 19 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Services-Medical Laboratories (SIC 8071)
Listed as
GH (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Palo Alto, CA
SEC filer status
Large accelerated filer
SEC CIK
1576280

Other Services-Medical Laboratories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.